All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Effect of Combining Ivabradine and ?-Blockers: Focus on the Use of Carvedilol in the SHIFT Population

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F15%3A33157491" target="_blank" >RIV/61989592:15110/15:33157491 - isvavai.cz</a>

  • Result on the web

    <a href="http://Effect" target="_blank" >http://Effect</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1159/000380812" target="_blank" >10.1159/000380812</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Effect of Combining Ivabradine and ?-Blockers: Focus on the Use of Carvedilol in the SHIFT Population

  • Original language description

    OBJECTIVES: We explored the prescription of ?-blockers with ivabradine in patients with systolic heart failure, focusing on the most frequently coprescribed ?-blocker, carvedilol. METHODS: We analyzed outcomes in SHIFT patients with systolic heart failure who were prescribed ?-blockers (carvedilol, bisoprolol, metoprolol, or nebivolol) with ivabradine or placebo. Analysis was by intention to treat in patients prescribed a ?-blocker at the time of the event. RESULTS: Data were available for 2,596 patients receiving carvedilol, 1,483 bisoprolol, 1,424 metoprolol, and 197 nebivolol. Mean treatment duration was 19 months. There was no difference in the effect of ivabradine on the primary composite endpoint of cardiovascular death or heart failure hospitalization between the various ?-blockers [hazard ratios (HR) for risk reduction, 0.75-0.89; p for interaction=0.86]. Patients prescribed carvedilol with ivabradine had lower rates of primary composite endpoint (HR 0.80, 95% CI: 0.68-0.94), h

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FA - Cardiovascular diseases including cardio-surgery

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Cardiology

  • ISSN

    0008-6312

  • e-ISSN

  • Volume of the periodical

    131

  • Issue of the periodical within the volume

    4

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    7

  • Pages from-to

    218-224

  • UT code for WoS article

  • EID of the result in the Scopus database